Researchers at Cornell Engineering and Weill Cornell Medicine have developed a hand-held cancer detection device. Called TINY due to its size, the Tiny Isothermal Nucleic acid quantification sYstem has potential to be an effective point-of-care detector of Kaposi sarcoma-associated herpesvirus (KSHV). Testing in resource-limited settings such as sub-Saharan Africa has resulted in about 94% agreement with traditional methods.
Kaposi sarcoma is a cancer that develops in lymph or blood vessels, usually appearing as lesions on the skin. Epidemic (AIDS-associated) KS is the most common type found in sub-Saharan Africa. Early detection leads to better outcomes, but the actual diagnosis process can take weeks. TINY has shown the ability to generate results in just 2 1/2 hours.
The researchers were able to collaborate using NYSERNet’s R&E network.
Read more about the team’s work on the device here.